Personalised Activity Plan for BREAKing UP Sitting Time in Patients With Peripheral Arterial Disease and Intermittent Claudication (The BREAK UP Study) (BREAK UP)
Intermittent claudication is the most common manifestation of peripheral arterial disease, a common cardiovascular disease that causes blocked blood vessels (arteries) in the leg. Symptoms consist of persistent pain in one or both legs during exercise that is relieved with rest. Evidence suggests that high levels of uninterrupted sitting and sedentary behaviour are associated with cardiovascular disease risk, mortality and all-cause mortality. One of the main goals for treating people with intermittent claudication, is increased participation in physical activity. Supervised Exercise Programmes are recommended however these are not well tolerated and compliance is low. Alternative exercise, including short bouts of physical activity to break up sedentary time, has been suggested to help improve physical function.
This study will investigate whether alternative exercise, in the form of breaking up prolonged sitting time, will improve physical function in patients with intermittent claudication.
Patients will be screened during their routine clinic appointment at Glenfield Hospital. All other study activity will take place at the patients home.
Activity monitors will be worn for up to 8 days at baseline and follow-up, measuring step count and time, inactivity, activity time and intensity, and sleep duration. Participants will also be expected to wear activity monitors for the duration of the 8-week intervention to measure steps. Participants will be in the study for up to 18 weeks in total.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Due to COVID-19 restrictions, the BREAK UP study is being conducted as an 8-week home-based before and after intervention study with the aim to improve physical function measured via the WIQ; and to reduce sitting time by up to 60 minutes per day, seven days a week.
Participants will be required to make contact with members of the research team twice to complete assessments remotely, once to complete a coaching consultation, and once per week during the 8-week activity plan to discuss their performance. Organisation of these, and any contact associated with recruitment may require more frequent contact with the research team via telephone or email.
Contact 1 (Recruitment/ eligibility):
Expression of interest to participate will be sought by the treating clinician at Glenfield hospital (listed on the delegation log), who will offer the patient a Participant Information Sheet, contact details form to complete and a consent form. The patient may then be approached by a member of the research team to take their consent, having read the information sheet, or if the participant is happy to be, a member of the research team will contact them within two weeks via telephone and/or email the participant to discuss the study in more detail and determine if they wish to participate or not. After which, they will be asked to complete the consent form and post this back to the research team. Once the signed and dated consent forms have been received, the researcher can organise for the baseline data to be collected.
Contact 2 (Baseline assessments):
Within 2 weeks participants will be required to complete baseline assessments which includes information on their date of birth/age, sex, ethnicity, smoking status, alcohol consumption, medical history (co-morbidities) and a number of questionnaires to assess their quality of life, breathlessness, anxiety and depression, fatigue and physical function. These will be completed over the telephone with the researcher or the researcher will post the questionnaires to the participants which will need to be completed and returned by post. These assessments will take approximately 1 hour.
Participants will also be posted two activity monitors (monitor 1 and 2) one of which will be wrist worn and the other thigh worn, as well as information on how to fit these. Participants will wear these for a period of up to 8 days to collect habitual physical activity data. A daily sleep-wake log will be used to collect data on participants sleep and wake-time, which will be posted, along with instructions on how to complete these, and returned via post along with the activity monitors.
Contact 3 (Coaching consultation):
Within 2 weeks participants will receive a telephone or video call which will be termed a "coaching consult", during which fourteen 2-minute activities to break sitting time will be discussed with a member of the research team. Video tutorials and/or instruction cards of these activities will be sent via post prior to the coaching consult. These activities and data from the habitual physical activity measure will be used to inform personalised activity plans whereby participants will be encouraged, using Bandura's social cognitive theory, to use these activities to reduce sitting time by up to 60 minutes per day for 8-weeks. This contact will take approximately 15 minutes. The 8-week activity plan will be prescribed, to complete at home and will begin within 2 weeks of this contact.
Participants will wear a wrist-worn activity monitor for the duration of the home-based 8-week intervention (monitor 3). They will be instructed on how to use these during the coaching consultation and how to complete daily diaries for monitor wear and activity completion for the 8-week period.
During the 8-week intervention participants will be contacted once a week via telephone or video to discuss their performance on the activity plan and completion of the daily diary. This will take approximately 15 minutes a week. A member of the research team will organise this over email or telephone.
A second 8-day habitual physical activity measurement period will take place during week 8 of the intervention. Activity monitors 1 and 2 will be posted to participants in good time along with instructions on how to fit these. During this second habitual physical activity measurement period participants will continue to wear wrist-worn activity monitor 3 as well.
Contact 4 (Follow-up):
Participants will then be contacted for their final assessments within one week of the end of the 8-week intervention. The follow-up assessments will include the same assessments as at baseline, except for one questionnaire, and will be completed via telephone with a member of the research team, or a researcher will be post these out to the participant for completion. The assessments will take approximately 1 hour.
Tipo de estudo
Inscrição (Antecipado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Leicester, Reino Unido, LE3 9QP
- Recrutamento
- J Perks
-
Contato:
- J Perks
- Número de telefone: 01162583669
- E-mail: jp549@le.ac.uk
-
Contato:
- E-mail: jp549@le.ac.uk
-
Investigador principal:
- Rob Sayers
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Men and women
- Age ≥18 years
- ABPI <0.9 or >1.4 at rest OR >20% decrease post exercise. When ABPI is >0.9 but there is clinical suspicion of PAD, other non-invasive tests, which may include imaging, will be used to confirm diagnosis.
- History of intermittent claudication (exercise induced, aching/cramping, pain affecting the lower limbs or buttocks, which subsides with rest)
- Able and willing to give informed consent
- Able to speak, read, and write English
- Able to undertake light physical activity
Exclusion Criteria:
- Individuals with type 1, gestational, or monogenic diabetes mellitus
- On insulin therapy
- Hospital admission in preceding 3 months
- Current or planned pregnancy, or breast feeding
- Contra-indications to exercise
- Participation in CTIMP currently and/or in preceding 3 months
- Already participating in a structured SEP
- Serious illness with life-expectancy < 1 year
- Previous major amputation
- Recent cardiovascular event (within the last 12 months)
- Comorbidity that the research team considered to be a contraindication to involvement in the study
- Unable to communicate in English
- Recent diagnosis or treatment for cancer (within 12 months)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Experimental
Participants will take part in an 8-week home-based activity plan to break up sitting time by 60 minutes per day.
|
This research study aims to prove efficacy of a home-based physical activity intervention targeted at reducing periods of prolonged sitting and improving physical function in patients with intermittent claudication.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
To investigate overall changes in sitting time
Prazo: 8 weeks
|
Measured using accelerometers (comparison of time spent sitting at baseline vs. follow-up assessed via acceleration)
|
8 weeks
|
|
The walking impairment questionnaire
Prazo: 8 weeks
|
Total score for 16 questions measuring walking distance, speed and stair climbing from 0 (worst/inability) to 4 (best/without limitations)
|
8 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
To investigate overall changes in time spent performing physical activity
Prazo: 8 weeks
|
Measured using accelerometers (comparison of time spent performing physical activity at baseline vs. follow up assessed via mean acceleration mg/day )
|
8 weeks
|
|
To investigate overall changes in time spent in light physical activity
Prazo: 8 weeks
|
Measured using accelerometers (comparison of time spent in light physical activity at baseline vs. follow up assessed via acceleration mins/day)
|
8 weeks
|
|
To investigate overall changes in time spent in moderate physical activity
Prazo: 8 weeks
|
Measured using accelerometers (comparison of time spent in moderate physical activity at baseline vs. follow up assessed via acceleration mins/day)
|
8 weeks
|
|
To investigate overall changes in time spent in vigorous physical activity
Prazo: 8 weeks
|
Measured using accelerometers (comparison of time spent in vigorous physical activity at baseline vs. follow up assessed via acceleration mins/day)
|
8 weeks
|
|
To investigate overall changes in time spent in prolonged sitting
Prazo: 8 weeks
|
Measured using accelerometers (comparison of time spent sitting at baseline vs. follow-up assessed via acceleration)
|
8 weeks
|
|
To investigate overall changes in time spent in sleep
Prazo: 8 weeks
|
Measured using accelerometers (comparison of time spent sleeping at baseline vs. follow-up assessed via acceleration)
|
8 weeks
|
|
To investigate whether personalised activity breaks in sitting time improve quality of life
Prazo: 8 weeks
|
Measured using the Vascular Quality of Life (VascuQoL) questionnaire
|
8 weeks
|
|
To investigate whether personalised activity breaks in sitting time improve quality of life
Prazo: 8 weeks
|
Measured using the Euro Quality of Life (EQ-5D-5L) questionnaire
|
8 weeks
|
|
To investigate whether personalised activity breaks in sitting time improve breathlessness
Prazo: 8 weeks
|
Measured using the modified medical research council (mMRC) dyspnoea scale
|
8 weeks
|
|
To investigate whether personalised activity breaks in sitting time improve fatigue
Prazo: 8 weeks
|
Measured using Chalder's Fatigue Scale
|
8 weeks
|
|
To investigate whether personalised activity breaks in sitting time improve anxiety and depression
Prazo: 8 weeks
|
Measured using the hospital anxiety and depression scale
|
8 weeks
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 0795
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CSR
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .